Show simple item record

dc.contributor.authorCooksley, Timothy J
dc.contributor.authorHolland, M
dc.contributor.authorKlastersky, J
dc.date.accessioned2016-01-22T13:54:10Zen
dc.date.available2016-01-22T13:54:10Zen
dc.date.issued2015en
dc.identifier.citationAmbulatory outpatient management of patients with low risk febrile neutropaenia. 2015, 14 (4):178-81 Acute Meden
dc.identifier.issn1747-4892en
dc.identifier.pmid26726789en
dc.identifier.urihttp://hdl.handle.net/10541/594591en
dc.description.abstractPatients with febrile neutropenia are a heterogeneous group with only a minority developing significant medical complications. Scoring systems, such as the Multinational Association for Supportive Care in Cancer (MASCC) score, have been developed and validated to identify low risk patients. Caring for patients with low risk febrile neutropenia in an ambulatory setting is proven to be safe and effective. Benefits include admission avoidance, cost savings and reduced risk of nosocomial infections, as well as improved patient experience and satisfaction. Implementation of an ambulatory pathway for low risk febrile neutropenia provides an excellent opportunity for Acute Physicians and Oncologists to collaborate in delivering care for this group of patients.
dc.language.isoenen
dc.rightsArchived with thanks to Acute medicineen
dc.titleAmbulatory outpatient management of patients with low risk febrile neutropaenia.en
dc.typeArticleen
dc.contributor.departmentHonorary Consultant, The Christie and Consultant in Acute Medicineen
dc.identifier.journalAcute Medicineen
html.description.abstractPatients with febrile neutropenia are a heterogeneous group with only a minority developing significant medical complications. Scoring systems, such as the Multinational Association for Supportive Care in Cancer (MASCC) score, have been developed and validated to identify low risk patients. Caring for patients with low risk febrile neutropenia in an ambulatory setting is proven to be safe and effective. Benefits include admission avoidance, cost savings and reduced risk of nosocomial infections, as well as improved patient experience and satisfaction. Implementation of an ambulatory pathway for low risk febrile neutropenia provides an excellent opportunity for Acute Physicians and Oncologists to collaborate in delivering care for this group of patients.


This item appears in the following Collection(s)

Show simple item record